Skip to main content

Write a review and win an AirPods Pro or MacBook Air — See the draw

B

Home health / DCT (decentralized trials)

Biofourmis

Leave a Review Website

At a glance

  • Global health IT company focusing on personalized care and digital therapeutics. $443.5M funded. Provides remote patient monitoring and predictive analytics…
  • Coverage: Global · Phase I–IV
  • Therapeutic focus: Cardiovascular, Respiratory, Oncology, Neurology and 1 more
  • Scale: Medium,Large,Global

Company fit

Best suited for

Remote patient monitoring,Digital therapeutics,Predictive analytics,DCT-enabling technology

Study fit

Enterprise-grade platform for sponsors needing comprehensive remote monitoring and digital therapeutics.

Core strengths

  • $443.5M funded
  • Enterprise-grade platform
  • Predictive analytics

Considerations

  • Complex implementation
  • Premium pricing

Key facts

Category
Home health / DCT (decentralized trials)
Geography
Global
Service model
SaaS
Vendor type
Technology
HQ
United States

Vendor description

This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.